Structural Entry Filters:

Search Count: 8

6UIP image
6UIP
Dyrk1A Kinase Domain In Complex With A 6-Azaindole Derivative, Gnf2133.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:3.70 Å Release Date: 2020-03-04
Classification: TRANSFERASE
Ligands: Q8J

6BHZ image
6BHZ
Trastuzumab Fab D185A (Light Chain) Mutant.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.75 Å Release Date: 2018-02-14
Classification: IMMUNE SYSTEM
Ligands: EDO

6BI0 image
6BI0
Trastuzumab Fab N158A, D185A, K190A (Light Chain) Triple Mutant.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.06 Å Release Date: 2018-02-14
Classification: IMMUNE SYSTEM
Ligands: EDO

6BI2 image
6BI2
Trastuzumab Fab D185A (Light Chain) Mutant Biotin Conjugation.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.80 Å Release Date: 2018-02-14
Classification: IMMUNE SYSTEM
Ligands: EDO, BTN

4YMJ image
4YMJ
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: A New Class Of Potent And Selective Pan-Trk Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.00 Å Release Date: 2015-06-03
Classification: Transferase/Transferase inhibitor
Ligands: 4EJ, GOL, CL

4YNE image
4YNE
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: A New Class Of Potent And Selective Pan-Trk Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.02 Å Release Date: 2015-06-03
Classification: Transferase/Transferase inhibitor
Ligands: 4EK, SO4, GOL

4YPS image
4YPS
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: A New Class Of Potent And Selective Pan-Trk Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.10 Å Release Date: 2015-06-03
Classification: Transfease/Transferase Inhibitor
Ligands: 4F6, SO4

3V5Q image
3V5Q
Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.20 Å Release Date: 2012-02-08
Classification: TRANSFERASE/TRANSFERASE INHIBITOR
Ligands: CL, 0F4
Protein Functional Filters: